These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9559787)

  • 21. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects.
    Cimoch PJ; Lavelle J; Pollard R; Griffy KG; Wong R; Tarnowski TL; Casserella S; Jung D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):227-34. PubMed ID: 9495222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High exposure to zidovudine during the first 2 weeks of life and concentration-toxicity relationships.
    Hirt D; Warszawski J; Firtion G; Giraud C; Chappuy H; Lechenadec J; Benaboud S; Urien S; Blanche S; Tréluyer JM
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):555-62. PubMed ID: 23481669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity.
    Barry M; Howe JL; Back DJ; Swart AM; Breckenridge AM; Weller IV; Beeching N; Nye F
    Br J Clin Pharmacol; 1994 Jan; 37(1):7-12. PubMed ID: 8148221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
    Chien SC; Chow AT; Rogge MC; Williams RR; Hendrix CW
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1765-9. PubMed ID: 9257757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection.
    Morse GD; Portmore A; Olson J; Taylor C; Plank C; Reichman RC
    Antimicrob Agents Chemother; 1990 Mar; 34(3):394-7. PubMed ID: 2334151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of zidovudine in end-stage renal disease: influence of haemodialysis.
    Pachon J; Cisneros JM; Castillo JR; Garcia-Pesquera F; Cañas E; Viciana P
    AIDS; 1992 Aug; 6(8):827-30. PubMed ID: 1418779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.
    Boucher FD; Modlin JF; Weller S; Ruff A; Mirochnick M; Pelton S; Wilfert C; McKinney R; Crain MJ; Elkins MM
    J Pediatr; 1993 Jan; 122(1):137-44. PubMed ID: 8419601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphine pharmacokinetics in premature and mature newborn infants.
    Mikkelsen S; Feilberg VL; Christensen CB; Lundstrøm KE
    Acta Paediatr; 1994 Oct; 83(10):1025-8. PubMed ID: 7841696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of small-for-gestational age (SGA) status on gentamicin pharmacokinetics in neonates.
    Lulic-Botica M; Sheer T; Edwards D; Thomas RL; Natarajan G
    J Clin Pharmacol; 2014 Jan; 54(1):39-45. PubMed ID: 24122736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of gestational age on pharmacokinetics of alfentanil in neonates.
    Killian A; Davis PJ; Stiller RL; Cicco R; Cook DR; Guthrie RD
    Dev Pharmacol Ther; 1990; 15(2):82-5. PubMed ID: 2078976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic disposition of zidovudine during pregnancy.
    Watts DH; Brown ZA; Tartaglione T; Burchett SK; Opheim K; Coombs R; Corey L
    J Infect Dis; 1991 Feb; 163(2):226-32. PubMed ID: 1988507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
    Muller AE; DeJongh J; Bult Y; Goessens WH; Mouton JW; Danhof M; van den Anker JN
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3720-5. PubMed ID: 17646418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.
    Gibb D; Barry M; Ormesher S; Nokes L; Seefried M; Giaquinto C; Back D
    Br J Clin Pharmacol; 1995 May; 39(5):527-30. PubMed ID: 7669489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics of ceftizoxime in premature newborns.
    Karna P; Lee C; Kumar A; Dyke J; Gooch WM
    Dev Pharmacol Ther; 1993; 20(3-4):135-43. PubMed ID: 7828445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmacokinetics of zidovudine and its toxic catabolite 3'-amino-3'-deoxythymidine in HIV-infected patients.
    Zhou XJ; Sommadossi JP
    AIDS Res Hum Retroviruses; 1996 Feb; 12(3):229-33. PubMed ID: 8835201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of high-dose zidovudine administered as a continuous infusion in patients with cancer.
    Marchbanks K; Dudley MN; Posner MR; Darnowski J
    Pharmacotherapy; 1995; 15(4):451-7. PubMed ID: 7479197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of orally administered zidovudine among patients with hemophilia and asymptomatic human immunodeficiency virus (HIV) infection.
    Morse GD; Olson J; Portmore A; Taylor C; Plank C; Reichman RC
    Antiviral Res; 1989 Mar; 11(2):57-65. PubMed ID: 2729955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection.
    Wang LH; Chittick GE; McDowell JA
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1708-15. PubMed ID: 10390227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetic study of zidovudine in parenteral drug addicts with human immunodeficiency virus infection].
    Pachón J; Viciana P; Cisneros JM; García Pesquera F; Castillo JR; Cañas E
    Med Clin (Barc); 1993 Jan; 100(2):46-9. PubMed ID: 8429708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of rifabutin on the pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus.
    Gallicano K; Sahai J; Swick L; Seguin I; Pakuts A; Cameron DW
    Clin Infect Dis; 1995 Oct; 21(4):1008-11. PubMed ID: 8645788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.